58cfe80727
- Source: inbox/queue/2026-04-22-kff-medicare-glp1-bridge-lis-exclusion.md - Domain: health - Claims: 2, Entities: 1 - Enrichments: 2 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida <PIPELINE>
2.2 KiB
Medicare GLP-1 Bridge Program
Type: Federal demonstration program
Domain: Health policy, obesity treatment, Medicare coverage
Status: Active (July 1 - December 31, 2026)
Parent Agency: Centers for Medicare & Medicaid Services (CMS)
Overview
The Medicare GLP-1 Bridge Program is a temporary demonstration program providing coverage for GLP-1 receptor agonists (Wegovy and Zepbound) for obesity treatment in Medicare Part D beneficiaries. The program operates from July 1 through December 31, 2026, as a bridge to the longer BALANCE Model demonstration launching in January 2027.
Program Structure
Eligibility:
- BMI ≥35 alone, or
- BMI ≥27 with clinical criteria
- Must be enrolled in Medicare Part D
Cost-Sharing:
- Fixed $50 copayment per prescription
- Copay does NOT count toward Part D deductible
- Copay does NOT count toward $2,100 out-of-pocket cap
- Low-Income Subsidy (LIS) cost-sharing subsidies do NOT apply
Covered Medications:
- Wegovy (semaglutide)
- Zepbound (tirzepatide)
Legal Architecture
Medicare is statutorily prohibited from covering weight-loss drugs under standard Part D benefits. The Bridge program operates as a temporary exception requiring CMS demonstration authority, not durable legislative change. This legal constraint forced the program to operate outside standard Part D benefit structures, which creates the LIS exclusion.
Eligible Population
Up to ~14 million Medicare beneficiaries had diagnosed overweight/obesity in 2020, representing the potential eligible pool.
Continuity Planning
Beneficiaries who want continued GLP-1 coverage in 2027 may need to switch Part D plans during open enrollment, as the Bridge program is temporary and does not guarantee continued coverage.
Related Programs
- BALANCE Model (Medicare Part D): Launches January 2027 as longer-term demonstration
- BALANCE Model (Medicaid): Launches May 2026
Timeline
- 2026-04 — Program announced by CMS
- 2026-07-01 — Program begins
- 2026-12-31 — Program ends
- 2027-01 — BALANCE Model (Medicare Part D) launches
Sources
- KFF Health Policy analysis (April 2026)
- CMS program documents